Biolinerx ltd. (BLRX)
Income statement / Yearly
Dec'17Dec'16Dec'15
RESEARCH AND DEVELOPMENT EXPENSES

19,510

11,177

11,489

SALES AND MARKETING EXPENSES

1,693

1,352

1,003

GENERAL AND ADMINISTRATIVE EXPENSES

4,037

3,984

3,704

OPERATING LOSS

-25,240

-16,513

-16,196

NON-OPERATING INCOME (EXPENSES), NET

-260

214

1,445

FINANCIAL INCOME

1,169

480

457

FINANCIAL EXPENSES

21

22

106

NET LOSS AND COMPREHENSIVE LOSS

-24,352

-15,841

-14,400

LOSS PER ORDINARY SHARE - BASIC AND DILUTED

-0.27

-0.28

-0.28

WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF LOSS PER ORDINARY SHARE

89,970

56,144

51,406